Cantel Medical Strikes Another Dental Deal

Cantel Medical Corp. (NYSE: CMD) acquired another medical device company last week, Hu-Friedy Mfg. Co., LLC. The target company has a long history as a dental instrument manufacturer, providing instrument reprocessing workflow systems that have served the dental industry for over 111 years. Cantel agreed to pay $725 million upfront, $60 million of which will be paid in Cantel stock […]

 

Health Care M&A Deals, Week Ending August 2, 2019

The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to […]

 

 

After a Two-Year Buying Spree, Bain Sells Majority Stake in Waystar

Almost two years ago, in September 2017, Bain Capital Private Equity acquired cloud-based revenue cycle management (RCM) company ZirMed for a reported $750 million and merged it with its own revenue cycle management company, Navicure. The combination formed Waystar, which integrated ZirMed’s business and clinical performance management solutions with Navicure’s own cloud-based RCM platform that focused on medical […]

 

CRO and CDMO
CRO and CDMO

Global Cancer Diagnostics Platform Announced

Big Pharma is racing to find a cure for all types of cancer. Now there’s a $2.8 billion deal that unites two cancer diagnostics companies. Exact Sciences Corporation (NYSE: EXAS), a molecular diagnostics company and maker of the Cologuard colorectal screening test, announced its acquisition of Genomic Health, Inc. (NASDAQ: GHDX) in late July. Genomic […]

Q2:19 Healthcare Deal Value, Services vs. Technology

Healthcare deal value in the second quarter totaled $138.7 billion, a slight 7% decrease from the first quarter’s $149.0 billion. Both quarters in 2019 featured a single, mega-billion-dollar deal—the $74 billion Bristol-Myers Squibb/Celgene deal in Q1 and the $87 billion AbbVie/Allergan hook-up in Q2—while the second quarter of 2018 included Takeda’s $81.5 billion deal for […]

Health Care M&A Deals, Week Ending July 26, 2019

The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to […]

Health Care M&A Deals, Week Ending July 19, 2019

The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to […]